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Abstract
Background: High density lipoprotein (HDL) was reported to decrease plasma glucose and promote insulin secretion in
type 2 diabetes patients. This investigation was designed to determine the effects and mechanisms of HDL on glucose
uptake in adipocytes and glycogen synthesis in muscle cells.
Methods and Results: Actions of HDL on glucose uptake and GLUT4 translocation were assessed with 1-[
3H]-2-
deoxyglucose and plasma membrane lawn, respectively, in 3T3-L1 adipocytes. Glycogen analysis was performed with
amyloglucosidase and glucose oxidase-peroxidase methods in normal and palmitate-treated L6 cells. Small interfering RNA
was used to observe role of scavenger receptor type I (SR-BI) in glucose uptake of HDL. Corresponding signaling molecules
were detected by immunoblotting. HDL stimulated glucose uptake in a time- and concentration-dependent manner in 3T3-
L1 adipocytes. GLUT4 translocation was significantly increased by HDL. Glycogen deposition got enhanced in L6 muscle
cells paralleling with elevated glycogen synthase kinase3 (GSK3) phosphorylation. Meanwhile, increased phosphorylations
of Akt-Ser473 and AMP activated protein kinase (AMPK) a were detected in 3T3-L1 adipocytes. Glucose uptake and Akt-
Ser473 activation but not AMPK-a were diminished in SR-BI knock-down 3T3-L1 cells.
Conclusions: HDL stimulates glucose uptake in 3T3-L1 adipocytes through enhancing GLUT4 translocation by mechanisms
involving PI3K/Akt via SR-BI and AMPK signaling pathways, and increases glycogen deposition in L6 muscle cells through
promoting GSK3 phosphorylation.
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Introduction
Lower plasma levels and dysfunction of high density lipoprotein
(HDL) are closely associated with metabolic syndrome including
cardiovascular diseases, obesity, dyslipidemia and type 2 diabetes
mellitus [1]. ABCA1 and ABCG1 are severely decreased in type 2
diabetes mellitus, which inhibit HDL formation and mature due to
lower efflux of cholesterol and phospholipid from peripheral
tissues [2,3]. Scavenger receptor type I (SR-BI) that mediates HDL
uptake is highly expressed under elevated glucose circumstance
[4]. Furthermore, other proteins regulating HDL metabolism such
as cholesterol ester transfer protein, lecithin cholesterol acyltrans-
ferase, lipoprotein lipase are also involved in regulation of HDL in
type 2 diabetes mellitus [5,6,7]. Accumulated evidence suggests
that HDL enhancement play a beneficial role in maintaining
glucose homeostasis via insulin-dependent and -independent
pathways in type 2 diabetes mellitus. For insulin-dependent
mechanism, HDL reverses failure of oxidized LDL-induced beta
cells and counters apoptosis of LDL- and VLDL-stimulated beta
cells [8,9]. Moreover, HDL and apolipoprotein AI (apoAI)
promote glucose uptake and activate AMPK a in primary human
skeletal muscle cells by an insulin-independent way [10,11].
Meanwhile, oxidation metabolism is increased through phosphor-
ylation of acetyl-CoA carboxylase b in skeletal muscle following
the treatment of HDL [10].
Upon binding to SR-BI, HDL activates tyrosine kinase followed
by activation of phosphoinositide 3-kinase (PI3K), mitogen-
activated protein kinase pathways and Akt-phosphorylated
endothelial nitric oxide synthase (eNOS) of endothelial cells [12].
Both PI3K/Akt and AMPK signaling pathways positively evoke
glucose transporter 4 (GLUT4) exocytosis in the state of insulin
stimulation and various stress status such as exercise and hypoxia
[13,14,15]. GLUT4 is already identified as the most important
type of glucose transporters in maintaining glucose homeostasis.
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process between intracellular storage organelles and plasma
membrane with insulin stimulation is closely associated with
enhanced glucose uptake of adipocytes and skeletal muscle cells.
Whether GLUT4 is involved in the HDL-regulated glucose
metabolism is poorly depicted.
Net number of GLUT4 on cell surface is the consequence of
exocytosis coupled with endocytosis. Endocytotic process occurs via
clathrin- and/or caveolin-mediated manners. GLUT4 endocytosis
is inhibited by clathrin-coated pits disruption [16]. Moreover, the
internalization of GLUT4 is also associated with lipid raft
microdomains of calveolin-riched in plasma membrane, and
prevented by cholesterol depletion with agents such as methyl-b-
cyclodextrin and cholesterol oxidase [17,18]. Cholesterol depletion
influences caveolae and clathrin-coated pits structure and function,
and inhibition of GLUT4 endocytosis is reversed by cholesterol
replenishment [17]. Meanwhile, rapid and specific cholesterol
depletion of HDL from caveolae is observed [19]. However, direct
evidence is required to reveal the role of reverse cholesterol
transport, a typical function of HDL, in endocytotic process.
Following glucose uptake, glycogen synthesis is one of
glucotropic effects of insulin. Glycogen synthase kinase-3 (GSK3)
inhibits glycogen synthesis through glycogen synthase (GS)
phosphorylation, which disrupts glucose homeostasis and favors
insulin resistant status [20]. GSK3b activation is attenuated by
phosphorylation following insulin-stimulated Akt phosphorylation
[21]. Inactivation of GSK3b leads to GS dephosphorylation and
glycogen synthesis inhibition in adipose, muscle and liver.
Glycogen storage reduction in skeletal muscle is the phenotype
of type 2 diabetes patients. Therefore, GSK3b, one of isoforms of
GSK3, is an important enzyme in regulating glucose metabolism
and acts as a key target in treatment of type 2 diabetes mellitus.
In the present study, we investigate the influences of HDL on
glucose uptake and GLUT4 translocation in 3T3-L1 adipocytes
and glycogen synthesis in L6 cells to provide more evidences for
HDL in regulating glucose homeostasis. The results indicate that
HDL promotes glucose uptake in adipocytes via enhancement of
GLUT4 translocation that may be through SR-BI, and increases
glycogen deposition in skeletal muscle cell following phosphory-
lation of GSK3.
Results
HDL Stimulates Glucose Uptake in 3T3-L1 Adipocytes
To investigate the effect of HDL on glucose uptake, 1-[
3H]-2-
deoxyglucose uptake was directly assessed in 3T3-L1 adipocytes
incubated with HDL for 30 min. HDL increased glucose uptake of
3T3-L1 adipocytes in a concentration-dependent fashion with
significant effect at the range from 25 to 100 mg protein/ml
(Figure 1A and 1B), consistent with previous report [10]. Time-
dependent effect of HDL on glucose uptake was obtained during a
period of 60 min, and dramatic increase of glucose uptake was
observed at 20 min and no further enhancement was revealed
(Figure 1C). To further investigate which pathways might be
involved in the process of glucose uptake stimulated by HDL, cells
were treated with HDL combined with LY294002, L-NAME and
PD98059, respectively. Both LY294002 and L-NAME significant-
ly blocked glucose uptake initiated by HDL, but no pronounced
blockade of PD98059 was detected (Figure 1D). Meanwhile,
similar enhancement in glucose uptake was simultaneously
observed with apoAI incubation. These results show that HDL
obviously stimulate glucose uptake through PI3K/Akt and eNOS-
associated pathways. ApoAI may be the major component to
mediate this action.
HDL Increases Glycogen Synthesis in L6 Cells
To further investigate whether glycogen synthesis was modu-
lated by HDL, glycogen content was determined as glycosyl units
with amyloglucosidase. As the data indicated, glycogen contents
markedly increased in L6 skeletal muscle cells after acute HDL
exposure (Figure 2A). Our data also showed that HDL induced
GSK3a and GSK3b phosphorylations in L6 muscle cells,
contributing to the increase of glycogen synthesis (Figure 2B and
2C). Moreover, excessive free fatty acids (FFAs) were documented
to induce insulin resistance and glycogen synthesis inhibition [22].
HDL treatment reversed the glycogen synthesis decrease and
GSK3b activation caused by high levels of palmitate in L6 cells
(Figure 2D and 2E). These results indicate that HDL enhances the
deposition of glycogen in muscle cells through phosphorylation of
GSK3b.
HDL Enhances GLUT4 Exocytosis and Inhibits GLUT4
Endocytosis in 3T3-L1 Adipocytes
We subsequently investigated whether GLUT4 participated in
the regulation of glucose utilization by HDL. Incubation of 3T3-
L1 adipocytes with 50 mg protein/ml HDL increased GLUT4
exocytosis in a time-dependent manner and the maximal
fluorescence, representing GLUT4 amount, was obtained at
around 20 min after HDL exposure (Figure 3A), which was in
accordance with time-effect course of HDL on glucose uptake in
3T3-L1 adipocytes (Figure 1B). On the other hand, more
fluorescence was observed on membrane of HDL-treated cells
after incubation with FITC-CTB, which indicated a marked
reduction of CTB endocytosis (Figure 3B). CTB was commonly
employed to evaluate GLUT4 endocytosis via caveolin-dependent
mechanism. This result suggests that GLUT4 endocytosis may also
be inhibited by HDL. Since activations of signaling PI3K/Akt and
AMPK initiate glucose uptake through promoting GLUT4
translocation, phosphorylations of Akt and AMPKa were
subsequently detected. A significant elevation in both Akt and
AMPKa phosphorylations was observed after HDL exposure
(Figure 3C, 3D), which is consistent with HDL function in
endothelial [23,24]. These findings indicate that GLUT4 amount
in plasma membrane may increase with enhanced exocytosis
through Akt & AMPK pathways and delayed endocytosis
mediated by caveolin in the presence of HDL.
HDL Prompts Glucose Uptake via SR-BI
In addition to mediating reverse cholesterol transport between
cells and lipoprotein, SR-BI is also considered to realize
cardiovascular protection of HDL through activating downstream
signal molecules such as Akt, mitogen-activated protein kinase and
AMPK [23]. The roles of Akt and AMPK in glucose metabolism
prompt the hypothesis that SR-BI may directly mediate HDL
functions in glucose metabolism aforementioned. Glucose uptake
and phosphorylations of Akt and AMPKa were assessed in 3T3-
L1 adipocytes of SR-BI knock-down with RNA interference
(Figure 4A). Significant glucose uptake stimulated by HDL was
diminished in SR-BI knock-down (Figure 4B). Consistent with this
result, pronounced inhibition of Akt activation was observed with
lower SR-BI levels (Figure 4C). Unexpectedly, SR-BI knock-down
seemed to have no influence on AMPKa phosphorylation
(Figure 4D). These results demonstrate that SR-BI is an important
receptor for HDL in regulating glucose utilization.
Discussion
In the present study, we characterized that HDL stimulated
glucose uptake in 3T3-L1 adipocytes in concentration&time-
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glucose uptake was inhibited by LY294002 and L-NAME. It is
well known that PI3K is the upstream of Akt and NOS. NOS
activation could be modulated by HDL through Akt, which is
initiated through the binding of HDL to SR-BI [12,25,26,27].
Activation of PI3K/Akt and NOS promotes translocation of
GLUT4 vesicle to plasma membrane [28,29]. Therefore, it is
reasonable to think that PI3K-Akt-NOS works as one pathway to
regulate glucose uptake. Meanwhile, HDL prompted translocation
of GLUT4 to plasma membrane from intracellular storage
organelles. Any approach to expand retention of GLUT4 in
plasma membrane would lead to enhancement of glucose uptake
by peripheral tissues, especially skeletal muscle and adipose tissue.
PI3K/Akt and AMPK signaling pathways have been showed to
participate in GLUT4 exocytosis and activation [13,14,15].
GLUT4 translocation rather than its total amount variation plays
a crucial role under diabetic conditions. The present study
demonstrated that HDL prompted GLUT4 exocytosis in parallel
with activating both PI3K/Akt and AMPK signaling pathways.
Meanwhile, glucose transport in 3T3-L1 adipocytes with HDL
stimulation was disturbed in the presence of LY294002, consistent
with the results obtained in muscle cells infected with AMPK-DN
virus [10]. Moreover, GLUT4 endocytosis followed by its
dysfunction could be regulated through changing cholesterol
contents in plasma membrane. Both Chromium and methyl-b-
cyclodextrin are suggested to induce GLUT4 endocytosis coupled
to membrane cholesterol loss that leads to insulin sensitizing in
3T3-L1 adipocytes [18]. Cholesterol efflux mediated by HDL is
rapid and specific from lipid raft/caveolae, whereas that from non-
raft microdomains is slow and lipoprotein independent [19].
Cholesterol depletion from caveolae influences its organization
and structure, leading to internalization delay of GLUT4
mediated by caveolae [17,30]. Furthermore, TC10, downstream
of caveola/Cb1 signaling complex, has also been shown to be the
second signal to GLUT4 exocytosis. Our result that caveolae-
mediated CTB endocytosis was disturbed by HDL in 3T3-L1
adipocytes demonstrated HDL’s inhibitory effect on GLUT4
endocytosis. Multiple functions of caveolae, especially abundant in
adipocytes, have been discovered. The functions of caveolae
include lipid regulation, membrane proteins endocytosis and
mechanosensation [31]. Caveolin is the major membrane protein
of caveolae. Caveolin-1 and -3, isoforms of caveolin, have a direct
interaction with G proteins-coupled receptors, receptor tyrosine
kinases, and so on. Some protein interactions within caveolae
Figure 1. HDL stimulates glucose uptake in 3T3-L1 adipocytes. 3T3-L1 adipocytes were incubated with vehicle or stimulators for 30 min
before being incubated for another 30 min with 1-[
3H]-2- deoxyglucose. (A) 3T3-L1 adipocytes were incubated with vehicle (BSA), HDL (50 mg
protein/ml), insulin (100 nmol/L) or indicated combination. (B) 3T3-L1 adipocytes were incubated with vehicle and HDL of indicated concentrations.
(C) 3T3-L1 adipocytes were incubated with vehicle, HDL (50 mg protein/ml) at indicated time points. (D) 3T3-L1 adipocytes were incubated with
vehicle, HDL (50 mg protein/ml), apoAI (50 mg/ml) and indicated combination with LY294002 (2 mmol/L), L-NAME (2 mmol/L) and PD98059 (1 mmol/
L). Data are expressed as means6SEM of three independent experiments, n=6. * p,0.05, ** p,0.01, vs vehicle; ## p,0.01, vs HDL.
doi:10.1371/journal.pone.0023556.g001
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receptor pathway. The insulin signaling is augmented through
Cb1-CAP complex and flotillin mediates translocation of the
complex to caveolae followed by GLUT4-mediated glucose uptake
[16]. Moreover, cholesterol depletion from caveolae results in
change of structure and function, which ultimately interferes
GLUT4 exocytosis and endocytosis processes. SR-BI, the receptor
mediating cholesterol transport of HDL from peripheral tissues, is
reported to colocalize with calovae [32]. There are three putative
pathways to reasonably interpret the influence of HDL on glucose
uptake via GLUT4 translocation. First, Activation of PI3K/Akt
signaling pathway is achieved by binding with SR-BI receptor.
Second, HDL influences the recruit of dimeric Cb1-CAP complex
to flotillin in lipid raft through cholesterol depletion. Third, HDL
inhibits endocytosis process of GLUT4 mediated by caveolin.
Besides cholesterol transport from peripheral tissues to liver and
steroidogenic organs, SR-BI has been demonstrated to initiate
diverse HDL-induced kinase cascades. SR-BI mediates cellular
uptake of bioactive lipid such as S1P and its precursor sphingosine
from HDL, which facilitates the binding of S1P to Gi-coupled S1P
receptors and initiates following signaling activation [33]. On the
other hand, SR-BI modulates cholesterol distribution in plasma
membrane and influences the structure/morphology of mem-
brane. Depletion of cholesterol conducted by SR-BI from caveolae
inhibits assembly and activity of PPA2A/HePTP phosphatase
complex, which subsequently results in decreased dephosphoryla-
tion of protein kinase targets such as ERK1/2 [34,35]. Direct
binding to SR-BI, HDL leads to activation of eNOS in endothelial
cells, which is regulated by PI3K/Akt signaling pathway and
mitogen activated protein kinases ERK1/2 pathway [12,27].
Moreover, migration of endothelial cells and inhibition of
adhesion molecules could also be regulated by the interaction of
HDL and SR-BI. In the present study, using RNA interference, we
provide evidence that SR-BI is involved in glucose uptake
stimulated by HDL in 3T3-L1 adipocytes. The effect of HDL
on glucose uptake is reversed by SR-BI knock-down. Activation of
signaling molecule Akt is attenuated by the RNA interference of
SR-BI. Although it is well documented that SR-BI plays important
role in regulating glucose homeostasis by some indirect ways such
as increasing insulin secretion and inhibiting pancreatic b-cells
apoptosis [36], this work shows the direct effect of HDL on glucose
uptake in adipocytes.
Glucose transported in skeletal muscle is undergone oxidative
glucose disposal and/or synthesized into glycogen, which is
dependent on energy requirement of skeletal muscle. Deficiencies
of glycogen synthesis and storage in skeletal muscle are features of
Figure 2. HDL increases glycogen synthesis in L6 cells and muscle tissue in vivo. (A) L6 cells starved overnight were incubated with vehicle,
HDL (50 mg protein/ml), insulin (100 nmol/L) or indicated combination for 2 h, n=6. (B and C) GSK3a (B) and GSK3b (C) phosphorylation in lysates
from incubated L6 cells at basal condition and after incubation with stimulators as (A), n=3. (D) L6 cells were treated with palmitate (0.4 mmol/L) for
12 h followed by incubation with HDL of indicated concentrations for 2 h, n=6. (E) GSK3b phosphorylation in lysates from incubated L6 cells under
conditions as (D), n=3. Data are expressed as means6SEM of three independent experiments performed in vitro. * p,0.05, ** p,0.01, vs vehicle;
1 p,0.05, vs palmitate.
doi:10.1371/journal.pone.0023556.g002
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skeletal muscle is closely associated with enhanced plasma
concentration of FFAs in individuals with type 2 diabetes.
Elevated FFAs levels could reduce activity of hexokinase II, which
decreases glucose uptake into skeletal muscle and subsequently
inhibits nonoxidative glucose metabolism by inhibition of GS [37].
GSK3 is the downstream protein kinase of PI3K/Akt and AMPK
signaling molecules and regulates GS activity. The recent report
indicated that both HDL and apoAI increased glucose uptake and
fatty acid oxidation by activating AMPK and the upstream
CaMKK in skeletal muscle of type 2 diabetes subjects [10]. Our
present study showed that HDL increased glycogen synthesis in L6
cells. Glycogen storage enhancement was achieved through GSK-
3b phosphorylation. Higher FFAs were verified to decrease
glycogen synthesis by GSK-3b dephosphorylation, impair pan-
creatic islet secretion and disturb insulin signal transduction [22].
Here, we found that decreased glycogen content and increased
GSK-3b activation induced by palmitate in L6 muscle cells were
attenuated by HDL incubation. HDL-induced higher glycogen
levels in skeletal muscle could be completed by the direct
regulation of GSK3b. Increase of fatty acid oxidation is also
expected to involve in this result because elevated fatty acid
oxidation inhibits glucose oxidation which strengthens glycogen
synthesis.
In conclusion, the present investigation provides evidence that
HDL promotes glucose uptake in adipocytes by regulating GLUT4
translocation and increases glycogen deposition in skeletal muscle
cells. These findings provide new insights into the influences and
mechanisms involved in glucose metabolism of HDL.
Materials and Methods
Cell Culture
Murine-derived 3T3-L1 fibroblasts (Chinese Academy of Sciences
Committee Type Culture Collection cell bank, Shanghai)were
cultured in DMEM with 25 mmol/l glucose, supplemented with
10% FBS, 100 mg/ml streptomycin and 100 U/ml penicillin, under
an atmosphere of 95% air/5% CO2 at 37uC. 3T3-L1 fibroblasts
were differentiated into adipocytes 2 days post confluent with the
same DMEM medium containing 3-isobutyl-1-methylxanthine
(0.5 mmol/l, Sigma), dexamethasone (1 mmol/l, Sigma), insulin
(1 mg/l, Sigma) and 10% FBS. Induction medium was aspirated
and replaced by medium supplemented with 10% FBS and insulin
(1 mg/l) in the next 2 days. Thereafter, the cells were maintained for
Figure 3. HDL enhances GLUT4 exocytosis and inhibits GLUT4 endocytosis in 3T3-L1 adipocytes. (A) 3T3-L1 adipocytes were treated in
the absence and presence of 50 mg protein/ml HDL for indicated time points. GLUT4 was immunofluorescently labeled with GLUT4 antibody and
followed by FITC-conjugated goat anti-rabbit IgG incubation in plasma membrane sheets. (B) 3T3-L1 adipocytes were chilled to 4uC, and labeled with
FITC-cholera toxin B. Then adipocytes were incubated in the absence or presence of HDL for 2.5 h to allow cholera toxin B internalization. (C and D)
Akt (C) and AMPKa (D) phosphorylation in lysates from 3T3-L1 adipocytes incubated with vehicle and indicated stimulators analyzed with
corresponding antibodies. Data are expressed as mean6SEM of three independent experiments. n=3. * p,0.05, ** p,0.01, vs vehicle.
doi:10.1371/journal.pone.0023556.g003
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changed every other day. Adipocytes were identified with Oil-red
(Sigma) staining, and those expressed adipocyte phenotype .90%
were used. Before experiments, adipocytes were incubated in serum-
free medium containing 0.2% bovine serum albumin (BSA) for
starvation overnight.
Rat L6 skeletal muscle cells (Chinese Academy of Sciences
Committee Type Culture Collection cell bank, Shanghai) were
cultured in a-MEM supplemented with 10% FBS, 100 mg/ml
streptomycin and 100 U/ml penicillin, in an atmosphere of 95%
air/5% CO2 at 37uC. Cells were grown in 100 mm culture dish to
confluence and then switched to a-MEM containing 2% FBS and
differentiated for 12–14 days. Fully differentiated myotubes were
starved in serum-free medium containing 0.5% BSA overnight
prior to experiments.
Glucose Transport
3T3-L1 adipocytes were washed with KRPH buffer (5 mM
Na2HPO4, 20 mM HEPES, pH 7.4, 1 mM MgSO4,1 m M
CaCl2, 136 mM NaCl, 4.7 mM KCl, and 1% BSA) three times,
incubated with KRPH for 1 h, and either treated or untreated as
demonstrated in figure legends for specific times. Glucose
transport was analyzed by incubation in KRPH containing
0.5 mCi 1-[
3H]-2-deoxyglucose (GE Healthcare, Waukesha, WI)
and 50 mmol/l 2-deoxyglucose in the absence or presence of
10 mmol/l cytochalasin B (Sigma-Aldrich, Inc., St. Louis, MO).
The transport was stopped by rinsing the cells with ice-cold PBS
for three times. The adipocytes were lysed in 1% Triton X-100 at
37uC for 30 min, and then the aliquots were subjected to
scintillation counting.
Plasma Membrane Sheet Assay
The translocation of GLUT4 was assessed by plasma mem-
brane sheet assay [38]. 3T3-L1 fibroblasts were plated on poly-L-
lysine-coated glass coverslips in six-well plates and then differen-
tiated into adipocytes. For stimulation with acute HDL, adipocytes
was starved in serum free DMEM containing 0.5% BSA for 18 h,
and then washed twice with KRPH buffer (5 mmol/L Na2HPO4,
Figure 4. HDL prompts glucose uptake via SR-BI. (A) The relative expression of SR-BI to GAPDH in 3T3-L1 adipocytes with treatment of vehicle,
control siRNA and SR-BI siRNA. (B) Glucose uptake in 3T3-L1 adipocytes with and without SR-BI RNA interfering were incubated in the absence or
presence of HDL (50 mg protein/ml), n=6. (C and D) Akt (C) and AMPKa (D) phosphorylation in 3T3-L1 adipocytes with and without SR-BI RNA
interfering were incubated in the absence or presence of HDL (50 mg protein/ml), n=3. Data are expressed as mean6SEM of three independent
experiments. ** p,0.01, vs vehicle; 11 p,0.01, vs control RNA interfering.
doi:10.1371/journal.pone.0023556.g004
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CaCl2, 136 mmol/L NaCl, 4.7 mmol/L KCl, and 1% BSA)
followed by equilibration for 1 h at 37uC prior to the presence of
HDL (50 mg protein/mL). After HDL incubation for 0, 5, 10, 20,
40 min, we collected the coverslips with 3T3-L1 adipocytes and
rinsed them in ice-cold PBS. Subsequently, the cells were
incubated with 3 mL poly-L-lysine (0.5 mg/mL) in PBS for
1 min, and swollen by three successive 5-s rinses in a 100 mm dash
with 10 mL ice-cold hypotonic buffer (23 mmol/L KCl,
10 mmol/L HEPES pH 7.5, 2 mmol/L MgCl2, and 1 mmol/L
EGTA) and immediately transferred to 10 mL ice-cold sonication
buffer (70 mmol/L KCl, 30 mmol/L HEPES pH 7.5, 5 mmol/L
MgCl2, 3 mmol/L EGTA, 1 mmol/L dithiothreitol, and
0.1 mmol/L phenylmethyl-sulfonyl fluoride), and sonicated to
broken through placing a 5-mm sonication microprobe just touch
the surface of the buffer. For immunofluorescence labeling,
the plasma membrane lawn were rinsed two times with
ice-cold sonication buffer and placed in a solution containing
2% paraformaldehyde, 70 mmol/l KCl, 30 mmol/l HEPES,
pH 7.5, 5 mmol/l MgCl2, and 3 mmol/l EGTA for 20 min at
room temperature. The fixed lawn washed in PBS for 5 s were
blocked at 4uC overnight in PBS containing 5% skim dry milk and
incubated overnight at 4uC with a 1:100 dilution of polyclonal
rabbit GLUT4 antibody, and followed by PBS rinse for three
times and incubation with a 1:10 dilution of fluorescein
isothiocyanate (FITC)-conjugated goat anti-rabbit IgG for
60 min at room temperature. Fluorescence images were obtained
using Olympus (Olympus, Japan) Fluorescence microscopy.
Cholera Toxin B Uptake
The uptake of Cholera toxin B was determined as previous
description to measure caveola-mediated endocytosis [17]. Briefly,
3T3L1 adipocytes were rinsed twice with 37uC Hanks’ balanced
salt solution (HBSS) and then incubated in serum-free DMEM
containing 2% BSA and starved for 2 h. The cells were
subsequently chilled to 4uC and incubated with 4 mg/ml FITC-
cholera toxin B in serum-free DMEM containing 2% BSA.
Unbound toxin-B was removed by rinsing labeled cells four times
with chilled HBSS. Being treated, these labeled 3T3-L1 adipocytes
were incubated 2.5 h in the same medium at 37uC to allow
internalization and then fixed with 2% paraformaldehyde in
HBSS. The internalization of FITC-cholera toxin B was
monitored by fluorescence microscopy.
Immunoblotting
To obtain total protein, adipose tissue, gastrocnemius muscle or
indicated cells were lysised in RIPA buffer (500 mmol/l Tris-HCl
pH 7.4, 1 mmol/l EDTA, 150 mmol/l NaCl, 1% NP-40, 0.25%
Na-deoxycholate, 1 mmol/l phenylmethylsulfonl fluoride, and
protease inhibitor cocktail) and then centrifuged (12,000 rpm)
for 10 min at 4uC. The protein concentrations were determined
using Lowry protein assay reagent. Protein samples were
electrophoresed on a sodium dodecyl sulfate (SDS)- polyacryl-
amide gel after boiling for 5 min in SDS sample buffer. Proteins
blots were transferred to luminescence membranes (Millipore).
After electroblotting, the membranes were blocked with 5% skim
dry milk in TBS and Tween 20 (10 mmol/l Tris-HCl pH 7.4,
150 mmol/l NaCl, and 0.1% Tween 20) and then incubated at
4uC with the corresponding primary antibody diluted in blocking
buffer overnight. Membranes were incubated with the appropriate
second antibodies for 1 h at room temperature. Immunoreactive
bands were detected by the enhanced chemi-luminescence system.
The density of bands was quantified using a Gel-pro analyzer.
Glycogen Assay
Glycogen contents of L6 cells and muscle tissue were assayed as
described previously [39]. Briefly, well differentiated L6 cells in
100 mm dish were digested with 1 N NaOH at 80uC for 15 min.
Protein was then precipitated with an equal volume of 2 N
trichloroacetic acid and centrifuged at 10,000 g for 15 min.
Glycogen precipitation from the supernatant was achieved by
using 100% ethanol (2:1, v/v). The glycogen pellet was rinsed with
80% ethanol and reconstituted in water, and the conversion of
glycogen to glucose was performed with 1 mg/ml amyloglucosi-
dase (Sigma-Aldrich, Inc., St. Louis, MO) in 0.5 mol/l sodium
acetate buffer, PH 4.8. The resulting glucose concentration was
determined based on glucose oxidase-peroxidase enzyme system.
Small Interfering RNA Transfection
To knock-down SR-BI in 3T3-L1 cells, the lentiviral pLKO.1
vector carrying the sequence GGCTATGACGATCCCT-
TCGTGCATT was employed to produce virus for interfering
RNA of SR-BI [40]. 3T3-L1 cells were infected with lentiviral
supernatants generated from 293T cells by transient cotransfection
with lipofectAMINE2000 (Invitrogen, Carlsbad, CA). After 48 h,
3T3-L1 cells were selected with puromycin (2 mg/ml) for
additional 14 d and used for subsequent experiments. As a
control, pLKO.1 vector without insert was transfected simulta-
neously into separate cells under the same condition. RNA level
was assayed with quantitative real-time RT-PCR in SR-BI knock-
down cells.
Real-time RT-PCR
Total mRNA was isolated from 3T3-L1 with TRIzol according
to the manufacturer’s instructions (Invitrogen). RNA then was
reverse-transcribed with a TaqMan reverse transcription kit. Real-
time PCR was performed using an ABI 7300 system (Applied
Biosystems) under standard reaction conditions. SYBR Green
oligonucleotides (Applied Biosystems) were used for detection and
quantification of SR-BI mRNA levels, which were normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using the
DDCT method (Figure 2). The specificity of the PCR amplification
was verified by melting curve analysis of the final products. Primer
sequences used to amplify SR-BI and GAPDH were as follows [41]:
F: 59-CTCCCAGACATGCTTCCCATA-39 and R: 59-GTCAG-
CTTCATGGACCTGCA-39 for SR-BI;F :5 9-ATTCAACGG-
CACAGTCAAGG-39 and R: 59-TGGATGCAGGGATGATG-
TTC-39 for GAPDH.
Statistical Analysis
Results are expressed as means 6 SE and analyzed using one-
way ANOVA and Student’s t test. A Newman Keuls post hoc
analysis was conducted to pairwise multiple comparisons as
significance was reached by ANOVA. The difference was
considered to be statistically significant when P,0.05.
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